CohBar (CWBR) Competitors $0.49 0.00 (0.00%) (As of 10/31/2024 09:06 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends CWBR vs. NOVN, PPBT, ORGS, SHPH, CELZ, XCUR, VCNX, EVOK, BCDA, and ONCTShould you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Novan (NOVN), Purple Biotech (PPBT), Orgenesis (ORGS), Shuttle Pharmaceuticals (SHPH), Creative Medical Technology (CELZ), Exicure (XCUR), Vaccinex (VCNX), Evoke Pharma (EVOK), BioCardia (BCDA), and Oncternal Therapeutics (ONCT). These companies are all part of the "medical" sector. CohBar vs. Novan Purple Biotech Orgenesis Shuttle Pharmaceuticals Creative Medical Technology Exicure Vaccinex Evoke Pharma BioCardia Oncternal Therapeutics CohBar (NASDAQ:CWBR) and Novan (NASDAQ:NOVN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Is CWBR or NOVN more profitable? CohBar has a net margin of 0.00% compared to Novan's net margin of -128.61%. CohBar's return on equity of 0.00% beat Novan's return on equity.Company Net Margins Return on Equity Return on Assets CohBarN/A N/A N/A Novan -128.61%-700.28%-39.58% Does the media prefer CWBR or NOVN? In the previous week, CohBar's average media sentiment score of 0.00 equaled Novan'saverage media sentiment score. Company Overall Sentiment CohBar Neutral Novan Neutral Does the MarketBeat Community favor CWBR or NOVN? Novan received 221 more outperform votes than CohBar when rated by MarketBeat users. However, 72.00% of users gave CohBar an outperform vote while only 53.35% of users gave Novan an outperform vote. CompanyUnderperformOutperformCohBarOutperform Votes1872.00% Underperform Votes728.00% NovanOutperform Votes23953.35% Underperform Votes20946.65% Which has preferable valuation and earnings, CWBR or NOVN? CohBar has higher earnings, but lower revenue than Novan. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCohBarN/AN/A-$12.18MN/AN/ANovan$24.71M0.00-$31.31M-$1.32N/A Do insiders and institutionals hold more shares of CWBR or NOVN? 2.5% of CohBar shares are owned by institutional investors. Comparatively, 14.5% of Novan shares are owned by institutional investors. 6.5% of CohBar shares are owned by company insiders. Comparatively, 1.3% of Novan shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate CWBR or NOVN? Given Novan's higher probable upside, analysts clearly believe Novan is more favorable than CohBar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CohBar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANovan 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has more volatility & risk, CWBR or NOVN? CohBar has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Novan has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. SummaryCohBar beats Novan on 7 of the 11 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get CohBar News Delivered to You Automatically Sign up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CWBR vs. The Competition Export to ExcelMetricCohBarPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.43M$6.75B$5.02B$8.42BDividend YieldN/A7.94%7.49%4.16%P/E RatioN/A11.78128.4816.64Price / SalesN/A288.471,723.1677.30Price / CashN/A46.0936.9033.53Price / Book0.095.284.595.19Net Income-$12.18M$150.82M$113.94M$223.67M7 Day Performance-2.00%-0.69%110.64%2.76%1 Month PerformanceN/A15.56%124.65%8.82%1 Year Performance-41.53%37.06%155.07%29.33% CohBar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CWBRCohBarN/A$0.49flatN/A-41.5%$1.43MN/A0.0010NOVNNovanN/AN/AN/AN/A$2.64M$24.71M-0.0790Analyst ForecastGap UpHigh Trading VolumePPBTPurple Biotech2.708 of 5 stars$3.35+4.4%$200.00+5,870.1%N/A$4.46MN/A-0.2620News CoverageORGSOrgenesis1.8193 of 5 stars$1.15-3.8%N/AN/A$5.52M$530,000.000.00150Upcoming EarningsNews CoveragePositive NewsGap UpSHPHShuttle Pharmaceuticals1.3368 of 5 stars$1.83-2.1%N/AN/A$5.40MN/A-0.535Upcoming EarningsCELZCreative Medical Technology1.2651 of 5 stars$4.02-2.9%N/A-13.5%$5.35M$17,000.00-0.995Gap UpXCURExicure2.3665 of 5 stars$3.07+1.3%N/A+401.6%$5.31M$28.83M-0.6750VCNXVaccinex1.3851 of 5 stars$2.93+5.0%N/A-77.3%$5.07M$570,000.00-0.0540Upcoming EarningsEVOKEvoke Pharma0.7224 of 5 stars$6.14+5.0%N/A-59.4%$5.03M$7.53M-0.384Analyst ForecastGap UpBCDABioCardia2.5891 of 5 stars$2.37+1.7%$25.00+954.9%-60.2%$5.02M$480,000.00-0.4416Gap UpONCTOncternal Therapeutics2.4567 of 5 stars$1.61+10.0%$20.00+1,145.5%-79.2%$4.75M$790,000.00-0.1330Analyst Forecast Related Companies and Tools Related Companies Novan Alternatives Purple Biotech Alternatives Orgenesis Alternatives Shuttle Pharmaceuticals Alternatives Creative Medical Technology Alternatives Exicure Alternatives Vaccinex Alternatives Evoke Pharma Alternatives BioCardia Alternatives Oncternal Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CWBR) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CohBar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
